甲状腺アブレーション装置市場レポート：動向、予測、競合分析 (2031年まで)

世界の甲状腺アブレーション装置市場の将来は、病院、外来手術センター、がん専門センター市場に機会があり、有望視されています。世界の甲状腺アブレーション装置市場は、2025年から2031年にかけてCAGR 9.7％で成長すると予想されています。この市場の主な促進要因は、甲状腺がんの罹患率の増加と低侵襲手術への傾斜の高まりです。

• Lucintelの予測では、種類別では高周波アブレーションが、迅速、安全、低侵襲で手術の代わりとなるなどの利点があるため、予測期間中も大きなセグメントであり続けます。
• 最終用途別では、病院が最大のセグメントであり続けると思われます。
• 地域別では、甲状腺がんの罹患率の上昇と同地域の大手企業の存在により、北米が予測期間中最大の地域であり続けると思われます。

甲状腺アブレーション装置市場の戦略的成長機会

甲状腺アブレーション装置市場は、低侵襲治療に対する需要の増加を活用しようとする利害関係者にとって、数多くの戦略的成長機会を提供しています。甲状腺疾患に対する認識が高まり、技術革新が進むにつれて、拡大の道がいくつか見えてきます。こうした機会を活用することで、企業は市場での存在感を高め、患者の治療成果を向上させながら持続可能な成長を推進することができます。

• 新興市場への進出：新興市場、特にアジアとラテンアメリカは、医療投資の増加と甲状腺の健康に対する意識の高まりにより、大きな成長の可能性を秘めており、企業にとって事業拡大の道となります。
• 併用療法の開発：甲状腺切除術とホルモン療法や標的薬治療などの他の治療法を統合する併用療法を開発する機会があり、これにより全体的な有効性と患者の満足度が高まる可能性があります。
• 患者中心のソリューションへの注力：企業は、教育プログラムやサポートサービスなどの患者中心のソリューションに投資することで、患者の関与と認識を高め、最終的に甲状腺切除術の需要を促進することができます。
• 戦略的パートナーシップとコラボレーション：医療提供者、研究機関、テクノロジー企業と戦略的パートナーシップを結ぶことで、イノベーションを促進し、新しい機器の流通を拡大し、市場への浸透を高め、専門知識を共有することができます。
• 研究開発への投資：研究開発への継続的な投資は、アブレーション技術とテクニックを進歩させ、進化する臨床ニーズに対応し、治療成績を向上させる新規機器の導入を可能にするために極めて重要です。

甲状腺アブレーション装置市場における戦略的成長機会は、メーカーにとっても医療提供者にとっても有望です。拡大、革新、協力に注力することで、利害関係者は市場での地位を高めるだけでなく、甲状腺管理における患者ケアの改善に大きく貢献することができます。

甲状腺アブレーション装置市場の促進要因・課題

甲状腺アブレーション装置市場は、いくつかの主要促進要因に後押しされて大きな成長を遂げています。同時に、市場拡大に影響を与えうる課題も残されています。これらのダイナミクスを理解することは、進化する甲状腺治療の展望を効果的にナビゲートすることを目指す利害関係者にとって極めて重要です。成長のカタリストと克服すべきハードルの両方を特定することは、この競争の激しい市場における戦略的意思決定に役立ちます。

甲状腺アブレーション装置市場を牽引する要因は以下の通りです：

• 甲状腺疾患の有病率の増加：甲状腺結節やがんを含む甲状腺疾患の罹患率の増加は、効果的な治療オプションに対する需要を促進し、甲状腺アブレーションを医療提供者の間でますます人気のある選択肢にしています。
• 低侵襲技術の進歩：高周波アブレーションやマイクロ波アブレーションなどの低侵襲アブレーション技術の革新は、より低侵襲な処置を求める患者を惹きつけ、市場の成長と普及に貢献しています。
• 認識と教育の高まり：甲状腺の健康や利用可能な治療オプションに対する患者や医療専門家の意識の高まりが、甲状腺アブレーション治療の需要拡大を促し、市場の認知度を高めています。
• 支持的な規制環境：新しい機器の承認プロセスが迅速化された良好な規制環境は、メーカーの技術革新と先進製品の市場投入を促し、成長をさらに促進します。
• 外来治療モデルの拡大：外来治療モデルへのシフトにより、甲状腺切除術へのアクセスが拡大しています。患者は、回復時間の短縮や、病院外で実施できる侵襲性の低い選択肢を好むからです。

甲状腺アブレーション装置市場の課題は以下の通りです：

• 装置の高コスト：特にコストに敏感な医療市場では、先進的な甲状腺アブレーション装置に関連する高コストが導入の障壁となる可能性があり、一部の患者や医療提供者のアクセスを制限しています。
• 臨床ガイドラインのばらつき：地域によって臨床ガイドラインや治療プロトコルが異なるため、医療提供者の間で混乱が生じ、甲状腺アブレーション技術の普及を妨げる可能性があります。
• 患者における認知度の低さ：認知度が向上しているにもかかわらず、多くの患者は治療の選択肢としての甲状腺アブレーションについて知らないままであり、このことが臨床におけるこの革新的な治療法の普及を遅らせる可能性があります。

結論として、甲状腺アブレーション装置市場は、技術の進歩や患者の意識の高まりなど、いくつかの強力な促進要因に支えられています。しかし、高コストやガイドラインのばらつきといった課題が成長を阻害する可能性があります。特定された促進要因を活用しながらこれらの課題に対処することは、この進化する市場で最大限の影響力を発揮することを目指す利害関係者にとって不可欠でしょう。

目次

第1章 エグゼクティブサマリー

第2章 世界の甲状腺アブレーション装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の甲状腺アブレーション装置市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の甲状腺アブレーション装置市場：種類別
  • 高周波アブレーション
  • マイクロ波アブレーション
  • その他
• 世界の甲状腺アブレーション装置市場：製品別
  • 熱ベースデバイス
  • 非熱ベースデバイス
• 世界の甲状腺アブレーション装置市場：用途別
  • 甲状腺がん
  • 甲状腺結節
  • その他
• 世界の甲状腺アブレーション装置市場：最終用途別
  • 病院
  • 外来手術センター
  • がん専門センター
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の甲状腺アブレーション装置市場：地域別
• 北米の甲状腺アブレーション装置市場
• 欧州の甲状腺アブレーション装置市場
• アジア太平洋の甲状腺アブレーション装置市場
• その他地域の甲状腺アブレーション装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の甲状腺アブレーション装置市場の成長機会：種類別
  • 世界の甲状腺アブレーション装置市場の成長機会：製品別
  • 世界の甲状腺アブレーション装置市場の成長機会：用途別
  • 世界の甲状腺アブレーション装置市場の成長機会：最終用途別
  • 世界の甲状腺アブレーション装置市場の成長機会：地域別
• 世界の甲状腺アブレーション装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の甲状腺アブレーション装置市場の生産能力拡大
  • 世界の甲状腺アブレーション装置市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

The future of the global thyroid ablation device market looks promising, with opportunities in the hospital, ambulatory surgical center, and cancer specialty center markets. The global thyroid ablation device market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing incidence of thyroid cancer and the rising inclination toward minimally invasive procedures.

• Lucintel forecasts that, within the type category, radiofrequency ablation will remain the larger segment over the forecast period due to its advantages, like being quick, safe, and less invasive substitutes for surgery.
• Within the end use category, the hospital will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to the rising incidence of thyroid cancer and the existence of key players in the region.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Thyroid Ablation Device Market

The thyroid ablation device market is rapidly evolving, influenced by technological advancements, changing patient preferences, and growing awareness of thyroid-related health issues. As healthcare professionals seek more effective and minimally invasive treatment options, several emerging trends are shaping the future of this market. These trends reflect innovations in device design, treatment methodologies, and patient care strategies, promising improved outcomes for individuals with thyroid disorders.

• Increased Adoption of Radiofrequency Ablation: Radiofrequency ablation (RFA) is gaining traction due to its minimally invasive nature, allowing for targeted destruction of thyroid nodules while preserving surrounding tissue. This leads to quicker recovery times for patients.
• Advancements in Imaging Techniques: Enhanced imaging technologies, such as ultrasound and CT scans, are playing a crucial role in improving the precision of thyroid ablation procedures, enabling better visualization of nodules and real-time monitoring during treatments.
• Development of Novel Devices: Manufacturers are focusing on the development of innovative ablation devices that combine multiple modalities, such as laser and microwave technologies, to improve efficacy, reduce procedure times, and expand treatment indications.
• Growing Patient Awareness: Increased awareness of thyroid disorders and treatment options is driving patient demand for minimally invasive procedures, prompting healthcare providers to adopt ablation techniques as a preferred choice over traditional surgery.
• Regulatory Support for New Technologies: Regulatory bodies are increasingly supportive of novel thyroid ablation devices, expediting approval processes and encouraging research and development. This is likely to spur market growth and innovation in the coming years.

The thyroid ablation device market is witnessing dynamic changes driven by these emerging trends. As technology continues to advance and patient needs evolve, the focus on minimally invasive and effective treatment options will likely dominate the market landscape, ultimately improving patient outcomes and satisfaction.

Recent Developments in the Thyroid Ablation Device Market

The thyroid ablation device market has seen remarkable developments in recent years, driven by technological innovation and an increasing focus on minimally invasive treatment options. These advancements aim to enhance patient outcomes, improve procedural efficiency, and expand the range of treatable conditions. As healthcare providers adopt these innovations, they are reshaping the landscape of thyroid management, providing patients with safer and more effective treatment alternatives.

• Launch of Advanced Ablation Systems: Recent launches of advanced ablation systems featuring improved radiofrequency and microwave technologies are enhancing precision in targeting thyroid nodules, leading to better outcomes and reduced complications.
• Integration of Artificial Intelligence: The integration of artificial intelligence in imaging and procedural planning is revolutionizing thyroid ablation, allowing for more accurate diagnoses and optimized treatment strategies, which significantly improve procedural success rates.
• Growth of Outpatient Procedures: There is a notable shift toward outpatient thyroid ablation procedures, driven by advancements in technology that enable faster recovery and reduced hospital stays, aligning with patient preferences for less invasive treatments.
• Expansion of Clinical Indications: New clinical studies are supporting the use of thyroid ablation for a broader range of indications, including larger nodules and recurrent cases, thereby expanding the patient population eligible for these minimally invasive therapies.
• Regulatory Approvals for Novel Devices: Recent regulatory approvals for innovative thyroid ablation devices are encouraging manufacturers to invest in research and development, fostering a competitive environment that enhances the overall quality and effectiveness of available treatments.

The recent developments in the thyroid ablation device market signal a transformative period for thyroid care. With advancements in technology, procedural approaches, and regulatory support, the future of thyroid management looks promising, offering patients safer and more effective treatment options tailored to their specific needs.

Strategic Growth Opportunities for Thyroid Ablation Device Market

The thyroid ablation device market presents numerous strategic growth opportunities for stakeholders seeking to capitalize on increasing demand for minimally invasive treatments. As awareness of thyroid disorders rises and technological innovations emerge, there are several avenues for expansion. By leveraging these opportunities, companies can enhance their market presence and drive sustainable growth while improving patient care outcomes.

• Expansion into Emerging Markets: Emerging markets, particularly in Asia and Latin America, offer significant growth potential due to rising healthcare investments and increasing awareness of thyroid health, providing an avenue for companies to expand their reach.
• Development of Combination Therapies: There is an opportunity to develop combination therapies that integrate thyroid ablation with other treatment modalities, such as hormonal therapy or targeted drug treatments, which could enhance overall efficacy and patient satisfaction.
• Focus on Patient-Centric Solutions: Companies can invest in patient-centric solutions, such as educational programs and support services, to increase patient engagement and awareness, ultimately driving demand for thyroid ablation procedures.
• Strategic Partnerships and Collaborations: Forming strategic partnerships with healthcare providers, research institutions, and technology firms can facilitate innovation and broaden the distribution of new devices, enhancing market penetration and fostering shared expertise.
• Investment in Research and Development: Continued investment in research and development is crucial for advancing ablation technologies and techniques, enabling the introduction of novel devices that meet evolving clinical needs and improve treatment outcomes.

The strategic growth opportunities within the thyroid ablation device market are promising for manufacturers and healthcare providers alike. By focusing on expansion, innovation, and collaboration, stakeholders can not only enhance their market positions but also significantly contribute to improved patient care in thyroid management.

Thyroid Ablation Device Market Driver and Challenges

The thyroid ablation device market is experiencing significant growth, propelled by several key drivers. At the same time, challenges remain that could impact market expansion. Understanding these dynamics is crucial for stakeholders aiming to navigate the evolving landscape of thyroid care effectively. Identifying both the catalysts for growth and the hurdles to overcome will help inform strategic decisions in this competitive market.

The factors responsible for driving the thyroid ablation device market include:

• Increasing Prevalence of Thyroid Disorders: The rising incidence of thyroid disorders, including nodules and cancer, is driving demand for effective treatment options, making thyroid ablation an increasingly popular choice among healthcare providers.
• Advancements in Minimally Invasive Techniques: Innovations in minimally invasive ablation technologies, such as radiofrequency and microwave ablation, are attracting patients seeking less invasive procedures, contributing to the market's growth and adoption.
• Growing Awareness and Education: Increased awareness of thyroid health and available treatment options among patients and healthcare professionals is fostering greater demand for thyroid ablation procedures, enhancing market visibility.
• Supportive Regulatory Environment: A favorable regulatory environment, with expedited approval processes for new devices, encourages manufacturers to innovate and bring advanced products to market, further driving growth.
• Expanding Outpatient Treatment Models: The shift toward outpatient care models is facilitating greater access to thyroid ablation procedures, as patients prefer shorter recovery times and less invasive options that can be performed outside of hospital settings.

Challenges in the thyroid ablation device market are:

• High Cost of Devices: The high cost associated with advanced thyroid ablation devices can be a barrier to adoption, particularly in cost-sensitive healthcare markets, limiting access for some patients and providers.
• Variability in Clinical Guidelines: Variability in clinical guidelines and treatment protocols across different regions can create confusion among healthcare providers, potentially hindering the widespread adoption of thyroid ablation techniques.
• Limited Awareness Among Patients: Despite growing awareness, many patients remain uninformed about thyroid ablation as a treatment option, which can slow down the uptake of these innovative therapies in clinical practice.

In conclusion, the thyroid ablation device market is buoyed by several strong drivers, including technological advancements and increasing patient awareness. However, challenges such as high costs and variability in guidelines may impede growth. Addressing these challenges while leveraging the identified drivers will be essential for stakeholders aiming to maximize their impact in this evolving market.

List of Thyroid Ablation Device Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, thyroid ablation device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid ablation device companies profiled in this report include-

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

Thyroid Ablation Device by Segment

The study includes a forecast for the global thyroid ablation device market by type, product, application, end use, and region.

Thyroid Ablation Device Market by Type [Analysis by Value from 2019 to 2031]:

• Radiofrequency Ablation
• Microwave Ablation
• Others

Thyroid Ablation Device Market by Product [Analysis by Value from 2019 to 2031]:

• Thermal Based Devices
• Non-Thermal Based Devices

Thyroid Ablation Device Market by Application [Analysis by Value from 2019 to 2031]:

• Thyroid Cancer
• Thyroid Nodules
• Others

Thyroid Ablation Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Cancer Specialty Centers
• Others

Thyroid Ablation Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Thyroid Ablation Device Market

The thyroid ablation device market has seen significant advancements recently, driven by technological innovations, the increasing prevalence of thyroid disorders, and growing awareness of minimally invasive treatment options. These developments are shaping the landscape of healthcare across various countries, including the United States, China, Germany, India, and Japan. Each of these markets is experiencing unique trends that reflect their healthcare needs and economic conditions, fostering a competitive environment for device manufacturers and healthcare providers.

• United States: The U.S. market is witnessing rapid growth due to advancements in ultrasound-guided radiofrequency ablation technology, leading to increased adoption of these procedures among endocrinologists and surgeons.
• China: The thyroid ablation device market in China is expanding quickly, propelled by rising healthcare investments and a growing patient population seeking effective treatments for thyroid nodules and cancer.
• Germany: The German market is characterized by a strong emphasis on research and development, with local manufacturers innovating new technologies to improve efficacy and patient outcomes in thyroid ablation procedures.
• India: The thyroid ablation market in India is evolving as awareness of non-surgical treatment options grows, supported by the increasing incidence of thyroid disorders and the entry of international players into the healthcare sector.
• Japan: Japan is experiencing a surge in thyroid ablation procedures, driven by advancements in imaging technologies and a shift towards minimally invasive treatments, leading to improved patient satisfaction and outcomes.

Features of the Global Thyroid Ablation Device Market

Market Size Estimates: Thyroid ablation device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Thyroid ablation device market size by various segments, such as by type, product, application, end use, and region in terms of value ($B).

Regional Analysis: Thyroid ablation device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end uses, and regions for the thyroid ablation device market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the thyroid ablation device market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid ablation device market by type (radiofrequency ablation, microwave ablation, and others), product (thermal based devices and non-thermal based devices), application (thyroid cancer, thyroid nodules, and others), end use (hospitals, ambulatory surgical centers, cancer specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Ablation Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Thyroid Ablation Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Thyroid Ablation Device Market by Type
  • 3.3.1: Radiofrequency Ablation
  • 3.3.2: Microwave Ablation
  • 3.3.3: Others
• 3.4: Global Thyroid Ablation Device Market by Product
  • 3.4.1: Thermal Based Devices
  • 3.4.2: Non-Thermal Based Devices
• 3.5: Global Thyroid Ablation Device Market by Application
  • 3.5.1: Thyroid Cancer
  • 3.5.2: Thyroid Nodules
  • 3.5.3: Others
• 3.6: Global Thyroid Ablation Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Cancer Specialty Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Thyroid Ablation Device Market by Region
• 4.2: North American Thyroid Ablation Device Market
  • 4.2.1: North American Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.3: European Thyroid Ablation Device Market
  • 4.3.1: European Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.4: APAC Thyroid Ablation Device Market
  • 4.4.1: APAC Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.5: ROW Thyroid Ablation Device Market
  • 4.5.1: ROW Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Thyroid Ablation Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Thyroid Ablation Device Market by Product
  • 6.1.3: Growth Opportunities for the Global Thyroid Ablation Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Thyroid Ablation Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Thyroid Ablation Device Market by Region
• 6.2: Emerging Trends in the Global Thyroid Ablation Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Thyroid Ablation Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Ablation Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific Corporation
• 7.2: BVM Medical System
• 7.3: Integra Life Sciences
• 7.4: Johnson & Johnson
• 7.5: Medtronic
• 7.6: MedWaves
• 7.7: Olympus Corporation
• 7.8: StarMed
• 7.9: Terumo Europe
• 7.10: Theraclion